Orange Book

OXALIPLATIN

OXALIPLATIN · 100MG/VIAL · INJECTABLE · INTRAVENOUS

ANDA078819HUMAN PRESCRIPTION DRUG
Open FDA's page for this record
Approval date
20100602
Product number
002
Products
  1. Brand name
    OXALIPLATIN
    Application name
    FRESENIUS KABI USA
    Application type
    A
    Application number
    078819
    Reference listed drug
    false
    Reference standard
    false
    Marketing status
    HUMAN PRESCRIPTION DRUG
    Application full name
    FRESENIUS KABI USA LLC
    Dosage form
    INJECTABLE
    Route
    INTRAVENOUS
    Active ingredients
    1. Name
      OXALIPLATIN
      Strength
      100MG/VIAL
    Therapeutic equivalence codes
    AP
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.